
    
      Methods and analysis: Blinded Randomized Controlled Trial (RCT) will be conducted. A total of
      108 participants will be randomly allocated to either a CBT-TLIF group or a PS-TLIF group at
      a ratio of 1:1. The primary clinical outcome measures are: change in back and lower limb pain
      with Visual analogue scale (VAS) and change in quality adjusted life years (QALY) will be
      assessed by EQ-5D-5L. Measurements will be carried out at five fixed time points
      (pre-operatively and at 3, 6, 12 and 24 months).

      Ethics and dissemination: The study had been reviewed and approved by the ethics committee of
      the Second affiliated hospital of the Wenzhou Medical University, Wenzhou,
      China(batch:2017-03). The results will be presented in peer-reviewed journals and related
      website within 2 years after the last operation.
    
  